Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brandau

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Research|June 26, 1999
Optimizing syngeneic orthotopic murine bladder cancer (MB49)J H Günther, A Jurczok, T Wulf, et al.
HNO|December 19, 2012
[Immunotherapy of head and neck cancer. Current developments]P J Schuler, T K Hoffmann, T C Gauler, et al.
The Journal of Urology|December 18, 2001
Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivoA Böhle, A Jurczok, P Ardelt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
In vitro generation of bacillus Calmette-Guérin-activated killer cellsS Brandau, A Böhle, A Thanhäuser, et al.
HNO|January 23, 2008
[Cell-based strategies for salivary gland regeneration]N Rotter, C Wirz, J Oder, et al.
HNO|September 30, 2020
[The microbiome in head and neck tumors-initial findings and outlook]S Lang, S Brandau, J R Marchesi, et al.
The Journal of Pathology|September 27, 2006
Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected miceS Aly, K Wagner, C Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cellsS Brandau, H Suttmann, J Riemensberger, et al.
International Journal of Cancer|May 8, 2001
NK cells are essential for effective BCG immunotherapyS Brandau, J Riemensberger, M Jacobsen, et al.
Laryngo- Rhino- Otologie|July 15, 2010
[Coagulation factors as potential tumour markers in patients with head and neck carcinomas?]J Greve, P J Schuler, M Bas, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Research|June 26, 1999
Optimizing syngeneic orthotopic murine bladder cancer (MB49)J H Günther, A Jurczok, T Wulf, et al.
HNO|December 19, 2012
[Immunotherapy of head and neck cancer. Current developments]P J Schuler, T K Hoffmann, T C Gauler, et al.
The Journal of Urology|December 18, 2001
Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivoA Böhle, A Jurczok, P Ardelt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
In vitro generation of bacillus Calmette-Guérin-activated killer cellsS Brandau, A Böhle, A Thanhäuser, et al.
HNO|January 23, 2008
[Cell-based strategies for salivary gland regeneration]N Rotter, C Wirz, J Oder, et al.
HNO|September 30, 2020
[The microbiome in head and neck tumors-initial findings and outlook]S Lang, S Brandau, J R Marchesi, et al.
The Journal of Pathology|September 27, 2006
Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected miceS Aly, K Wagner, C Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cellsS Brandau, H Suttmann, J Riemensberger, et al.
International Journal of Cancer|May 8, 2001
NK cells are essential for effective BCG immunotherapyS Brandau, J Riemensberger, M Jacobsen, et al.
Laryngo- Rhino- Otologie|July 15, 2010
[Coagulation factors as potential tumour markers in patients with head and neck carcinomas?]J Greve, P J Schuler, M Bas, et al.
Pageof 4